<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Clarity with
Crown

Recognize your next clinical candidate when you see it.

Our Translational Platforms enable our clients to identify the right patients for the right treatment. Having models which more accurately mimic human disease and population dynamics are key to successfully translating promising compounds into successful clinical candidates, whether treating Oncology or Diabetes related diseases.

Magnify your
insights

Understand the mechanisms of disease.

Our scientific acumen and experience will give you a deeper understanding of not just the pharmacological profile of your compound, but more importantly, a clear understanding of which compounds to progress into the clinic. Take a look at our publications to get a deeper understanding of the depth of our scientific expertise.

Begin with the
end insight

Connecting science to patients.

We help our clients solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease by answering some of the most challenging questions about human biology.

CVMD

Models of Obesity

obesity-img.jpg

CrownBio’s preclinical Translational Technology Platforms provide spontaneous & diet-induced obesity (DIO) models, to support the transition of new agents into the clinic.

Learn More

Oncology

Oncology Databases

databases-img.jpg

Our unique databases provide a curated source of well-characterized models available to use for drug discovery including PDX models, cell lines, and syngeneic models.

Learn More

CVMD

Diabetes Models

oncoexpress-img.jpg

Models of both Type 1 and Type 2 diabetes, including conventional, as well as unique, highly translatable models for in vivo efficacy studies of antidiabetic agents.

Learn More

Latest from our Blog

October 12, 2021

Accelerating Drug Discovery and Development with Flow Cytometry

In this post, we discuss modern flow cytometry as a game-changer for cell functional assays, immune monitoring, and function-based screening of drug candidates to support and accelerate your biomarker strategy and translational programs.

Read More

October 12, 2021

Accelerating Drug Discovery and Development with Flow Cytometry

In this post, we discuss modern flow cytometry as a game-changer for cell functional assays,...

Read More

September 14, 2021

Accelerating Cancer Drug Discovery with Digital Pathology-Based Biomarker Analysis

Digital pathology is an innovative technology that is transforming the field of modern pathology.

Read More

September 1, 2021

In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors

In this post we explore the different in vitro potency assays for assessing the function of...

Read More

August 16, 2021

Next-Generation Sequencing in Cell Line and Biosample Authentication

While the authentication of biosamples (i.e., cell lines, organoids, xenograft and homograft...

Read More

Upcoming Events


September 21-23, 2021

6th Annual PREDiCT: 3D Tissue Models Summit

The Colonnade Boston


September 30, 2021

TechTalk: Image-Based Quantification of Myeloid Cell Repolarization and their Interplay within the Tumor Microenvironment in 3D